A-SPIRE Heart Failure: Utilizing Health Tags to Identify Patients at Risk for Hospital Readmissions

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

36 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-13

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the use of the Spire Health Tags in heart failure patients to determine the feasibility of capturing signals of respiration, pulse rate, activity, sleep patterns, and stress levels following HF hospitalization.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Electronic S3 Prediction of Hospital Readmissions for HF Exacerbation

NCT04112849

Heart Failure Heart Failure With Reduced Ejection Fraction Heart Failure With Preserved Ejection Fraction

COMPLETED

Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions

NCT04905160

Heart Failure ADHF Acute MI

RECRUITING NA

A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure

NCT02084992

Congestive Heart Failure Diastolic Heart Failure Systolic Heart Failure

COMPLETED NA

Voice Analysis for Monitoring Patients With Heart Failure

NCT06566911

Heart Failure

RECRUITING

Serial Measurements of Biomarker in Patients With Acute Decompensated Heart Failure

NCT00514384

Acute Heart Failure

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Over 5 million Americans suffer from heart failure (HF), and treating HF as a chronic condition is associated with significant costs. In addition, about 24% of the patients discharged with a primary diagnosis of HF are readmitted to the hospital within 30 days, representing a significant public health burden. While there have been efforts to predict and reduce 30-day hospital readmission initiated by the Centers for Medicare and Medicaid Services (CMS), no studies utilized daily physiologic data from wearables to identify at-risk patients.

The overall goal of this proposed pilot feasibility study is to utilize the Spire Health Tags in a heart failure patient population to ascertain the feasibility of capturing appropriate signals of respiration, pulse rate, activity, sleep patterns, and stress levels (calm/focused/tense during the day) for \> 80% of the time in patients following HF hospitalization for a 30-day period. The investigators will do exploratory analysis of the changes in these physiologic variables during a 30-day period following HF hospitalization to identify risk markers that could predict 30-day readmission.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women 18 years of age or older;
* Admitted for acute heart failure;
* Expected to be discharged from hospitalization;
* Able to give consent;
* Willing to use the Spire Health Tags for 30 days continuously.